A large case series shows that catheter ablation of refractory ventricular arrhythmia in patients with cardiogenic shock can allow for liberation from mechanical support in most cases.
The studies explore a novel catheter that delivers both pulsed-field and radiofrequency energy, a new method for mapping and ablating scar-related ventricular tachycardia, and high-power/short-duration ablation for atrial fibrillation.
In ablation of scar-related ventricular tachycardia, mapping the heart during activation from multiple directions promises to improve clinical outcomes, suggests the international Physio-VT trial.
We’ve been pioneering use of the Impella 5.0 temporary LVAD to support patients with cardiogenic shock who need salvage ablation for ventricular tachycardia. This case study shares lessons learned to date.